Jeffrey Levine, MD
Obstetrics & Gynecology · Voorhees, NJNPI 1841369261
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Organon accounts for 93.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $13,900 and has fallen 98.6% since, to $197 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $182.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$14K
- Avion Pharmaceuticals$330
- Astellas Pharma US Inc$192
- Gilead$123
- Bayer$61
- AbbVie$46
- plus $206 from 9 others
What the payments were for
- Speaking & faculty fees$6,14842%
- Travel & lodging$7,47250%
- Food & beverage$1,1067%
- Education$851%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 9 | $13,855 |
| Avion Pharmaceuticals | 44 | $330 |
| Astellas Pharma US Inc | 7 | $192 |
| Gilead | 1 | $123 |
| Bayer | 3 | $61 |
| AbbVie | 3 | $46 |
| Pfizer | 2 | $37 |
| Exact Sciences | 2 | $35 |
| Scynexis, Inc. | 2 | $28 |
| Mayne Pharma Commercial LLC | 3 | $25 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Shield Therapeutics Inc | 1 | $21 |
| Merck | 1 | $15 |
| Exeltis, USA Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Truvada$123
How this compares
$14,811 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 19 | $1,214 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 15 | $302 |
| Fluconazole | 22 | $36 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Voorhees
- Geoffrey BowersVoorhees$228K
- Paula JasionowskiVoorhees$193K
- Richard DittrichVoorhees$9K
- Donna D EliaVoorhees$9K
- Jennifer AshtonEnglewood$1.5M
- Neha DeshpandePlainsboro$206K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.